Paper36551925
Pharmacogenetics and Schizophrenia-Can Genomics Improve the Treatment with Second-Generation Antipsychotics?
Płaza O and 5 others. Biomedicines, 2022. Cited by 14 papers, by iCite.
Cite this record
ConductScience Library. Pharmacogenetics and Schizophrenia-Can Genomics Improve the Treatment with Second-Generation Antipsychotics? Papers, record 36551925. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36551925
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Pharmacogenetics and Schizophrenia-Can Genomics Improve the Treatment with Second-Generation Antipsychotics?
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References86
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25056061 | Biological insights from 108 schizophrenia-associated genetic loci. | Nature | 2014 | https://conductscience.org/library/papers/25056061 | PubMed |
| 2 | 23842608 | Converging evidence for the association of functional genetic variation in the serotonin receptor 2a gene with prefrontal function and olanzapine treatment. | JAMA Psychiatry | 2013 | https://conductscience.org/library/papers/23842608 | PubMed |
| 3 | 26944100 | Detection of CYP2D6 polymorphism using Luminex xTAG technology in autism spectrum disorder: CYP2D6 activity score and its association with risperidone levels. | Drug Metab Pharmacokinet | 2016 | https://conductscience.org/library/papers/26944100 | PubMed |
| 4 | 33237321 | Association of CYP2C19 and CYP2D6 Poor and Intermediate Metabolizer Status With Antidepressant and Antipsychotic Exposure: A Systematic Review and Meta-analysis. | JAMA Psychiatry | 2021 | https://conductscience.org/library/papers/33237321 | PubMed |
| 5 | 19571811 | Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. | Nature | 2009 | https://conductscience.org/library/papers/19571811 | PubMed |
| 6 | 21750471 | Olanzapine metabolism and the significance of UGT1A448V and UGT2B1067Y variants. | Pharmacogenet Genomics | 2011 | https://conductscience.org/library/papers/21750471 | PubMed |
| 7 | 20060871 | MDR1 gene polymorphisms and response to acute risperidone treatment. | Prog Neuropsychopharmacol Biol Psychiatry | 2010 | https://conductscience.org/library/papers/20060871 | PubMed |
| 8 | 26320194 | Association of a Schizophrenia Risk Variant at the DRD2 Locus With Antipsychotic Treatment Response in First-Episode Psychosis. | Schizophr Bull | 2015 | https://conductscience.org/library/papers/26320194 | PubMed |
| 9 | 12202283 | Association of risperidone treatment response with a polymorphism in the 5-HT(2A) receptor gene. | Am J Psychiatry | 2002 | https://conductscience.org/library/papers/12202283 | PubMed |
| 10 | 19142110 | Association between HTR2C and HTR2A polymorphisms and metabolic abnormalities in patients treated with olanzapine or clozapine. | J Clin Psychopharmacol | 2009 | https://conductscience.org/library/papers/19142110 | PubMed |
| 11 | 32250470 | The effects of aripiprazole and olanzapine on pupillary light reflex and its relationship with pharmacogenetics in a randomized multiple-dose trial. | Br J Clin Pharmacol | 2020 | https://conductscience.org/library/papers/32250470 | PubMed |
| 12 | 25943458 | Comparative Pharmacology of Risperidone and Paliperidone. | Drugs R D | 2015 | https://conductscience.org/library/papers/25943458 | PubMed |
| 13 | 28719598 | The predictive value of ABCB1, ABCG2, CYP3A4/5 and CYP2D6 polymorphisms for risperidone and aripiprazole plasma concentrations and the occurrence of adverse drug reactions. | Pharmacogenomics J | 2018 | https://conductscience.org/library/papers/28719598 | PubMed |
| 14 | 15279048 | Offspring of parents with schizophrenia: mental disorders during childhood and adolescence. | Schizophr Bull | 2004 | https://conductscience.org/library/papers/15279048 | PubMed |
| 15 | 11520931 | Maternal care, gene expression, and the transmission of individual differences in stress reactivity across generations. | Annu Rev Neurosci | 2001 | https://conductscience.org/library/papers/11520931 | PubMed |
| 16 | 27388693 | Prediction of CYP2D6 phenotype from genotype across world populations. | Genet Med | 2017 | https://conductscience.org/library/papers/27388693 | PubMed |
| 17 | 34049235 | Toward personalized medicine in schizophrenia: Genetics and epigenetics of antipsychotic treatment. | Schizophr Res | 2021 | https://conductscience.org/library/papers/34049235 | PubMed |
| 18 | 24904434 | The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue. | Front Psychiatry | 2014 | https://conductscience.org/library/papers/24904434 | PubMed |
| 19 | 18786813 | Taq1A polymorphism in the dopamine D2 receptor gene as a predictor of clinical response to aripiprazole. | Eur Neuropsychopharmacol | 2008 | https://conductscience.org/library/papers/18786813 | PubMed |
| 20 | 18320559 | Dopamine receptor D3 genotype association with greater acute positive symptom remission with olanzapine therapy in predominately caucasian patients with chronic schizophrenia or schizoaffective disorder. | Hum Psychopharmacol | 2008 | https://conductscience.org/library/papers/18320559 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42317215 | Integrative Multiomics Analysis Identifies DKK3 as a Germline Susceptibility-Related Regulator of Risperidone Response and Metabolic Risk in Schizophrenia. | Hum Mutat | 2026 | https://conductscience.org/library/papers/42317215 | PubMed |
| 39379847 | Pharmacogenomics-assisted treatment versus standard of care in schizophrenia: a systematic review and meta-analysis. | BMC Psychiatry | 2024 | https://conductscience.org/library/papers/39379847 | PubMed |
| 39344086 | Unidentified CYP2D6 genotype does not affect pharmacological treatment for patients with first episode psychosis. | J Psychopharmacol | 2024 | https://conductscience.org/library/papers/39344086 | PubMed |
| 38988837 | Identification of differentially expressed genes of blood leukocytes for Schizophrenia. | Front Genet | 2024 | https://conductscience.org/library/papers/38988837 | PubMed |
| 38746691 | A systematic review of pharmacogenetic testing to guide antipsychotic treatment. | Nat Ment Health | 2024 | https://conductscience.org/library/papers/38746691 | PubMed |
| 38540209 | Impact of Pharmacogenetic Testing on Clozapine Treatment Efficacy in Patients with Treatment-Resistant Schizophrenia. | Biomedicines | 2024 | https://conductscience.org/library/papers/38540209 | PubMed |
| 38255270 | Long-Acting Injectable Second-Generation Antipsychotics in Seriously Ill Patients with Schizophrenia: Doses, Plasma Levels, and Treatment Outcomes. | Biomedicines | 2024 | https://conductscience.org/library/papers/38255270 | PubMed |
| 38030236 | Association of Antipsychotic Drugs with Venous Thromboembolism: Data Mining of Food and Drug Administration Adverse Event Reporting System and Mendelian Randomization Analysis. | J Atheroscler Thromb | 2024 | https://conductscience.org/library/papers/38030236 | PubMed |
| 38004520 | Pharmacogenetic Guidelines for Psychotropic Drugs: Optimizing Prescriptions in Clinical Practice. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/38004520 | PubMed |
| 37886115 | BDNF gene Val66Met polymorphisms as a predictor for clinical presentation in schizophrenia - recent findings. | Front Psychiatry | 2023 | https://conductscience.org/library/papers/37886115 | PubMed |
| 37880658 | Association of DRD2, DRD4 and COMT genes variants and their gene-gene interactions with antipsychotic treatment response in patients with schizophrenia. | BMC Psychiatry | 2023 | https://conductscience.org/library/papers/37880658 | PubMed |
Genes19
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36551925
GET https://conductscience.org/api/papers/v1/36551925/references?page=2